ID   TNR16_RAT               Reviewed;         425 AA.
AC   P07174;
DT   01-APR-1988, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1988, sequence version 1.
DT   02-OCT-2024, entry version 212.
DE   RecName: Full=Tumor necrosis factor receptor superfamily member 16;
DE   AltName: Full=Gp80-LNGFR;
DE   AltName: Full=Low affinity neurotrophin receptor p75NTR;
DE   AltName: Full=Low-affinity nerve growth factor receptor;
DE            Short=NGF receptor;
DE   AltName: Full=Low-affinity nerve growth factor receptor p75NGFR;
DE   AltName: Full=Low-affinity nerve growth factor receptor p75NGR;
DE   AltName: Full=p75 ICD;
DE   AltName: CD_antigen=CD271;
DE   Flags: Precursor;
GN   Name=Ngfr; Synonyms=Tnfrsf16;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=3027580; DOI=10.1038/325593a0;
RA   Radeke M.J., Misko T.P., Hsu C., Herzenberg L.A., Shooter E.M.;
RT   "Gene transfer and molecular cloning of the rat nerve growth factor
RT   receptor.";
RL   Nature 325:593-597(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-22.
RC   TISSUE=Liver;
RX   PubMed=1446821; DOI=10.1016/0378-1119(92)90128-c;
RA   Metsis M., Timmusk T., Allikmets R., Saarma M., Persson H.;
RT   "Regulatory elements and transcriptional regulation by testosterone and
RT   retinoic acid of the rat nerve growth factor receptor promoter.";
RL   Gene 121:247-254(1992).
RN   [3]
RP   INTERACTION WITH NTRK2.
RX   PubMed=9927421; DOI=10.1093/emboj/18.3.616;
RA   Bibel M., Hoppe E., Barde Y.A.;
RT   "Biochemical and functional interactions between the neurotrophin receptors
RT   trk and p75NTR.";
RL   EMBO J. 18:616-622(1999).
RN   [4]
RP   FUNCTION, AND INTERACTION WITH TRAF2; TRAF4 AND TRAF6.
RX   PubMed=10514511; DOI=10.1074/jbc.274.42.30202;
RA   Ye X., Mehlen P., Rabizadeh S., VanArsdale T., Zhang H., Shin H.,
RA   Wang J.J.L., Leo E., Zapata J.M., Hauser C.A., Reed J.C., Bredesen D.E.;
RT   "TRAF family proteins interact with the common neurotrophin receptor and
RT   modulate apoptosis induction.";
RL   J. Biol. Chem. 274:30202-30208(1999).
RN   [5]
RP   FUNCTION IN APOPTOSIS, AND INTERACTION WITH MAGED1.
RC   STRAIN=Sprague-Dawley; TISSUE=Neural crest;
RX   PubMed=10985348; DOI=10.1016/s0896-6273(00)00036-2;
RA   Salehi A.H., Roux P.P., Kubu C.J., Zeindler C., Bhakar A., Tannis L.-L.,
RA   Verdi J.M., Barker P.A.;
RT   "NRAGE, a novel MAGE protein, interacts with the p75 neurotrophin receptor
RT   and facilitates nerve growth factor dependent apoptosis.";
RL   Neuron 27:279-288(2000).
RN   [6]
RP   INTERACTION WITH KIDINS220.
RX   PubMed=11150334; DOI=10.1523/jneurosci.21-01-00176.2001;
RA   Kong H., Boulter J., Weber J.L., Lai C., Chao M.V.;
RT   "An evolutionarily conserved transmembrane protein that is a novel
RT   downstream target of neurotrophin and ephrin receptors.";
RL   J. Neurosci. 21:176-185(2001).
RN   [7]
RP   INTERACTION WITH NRADD.
RX   PubMed=12095158; DOI=10.1385/nmm:1:3:153;
RA   Frankowski H., Castro-Obregon S., del Rio G., Rao R.V., Bredesen D.E.;
RT   "PLAIDD, a type II death domain protein that interacts with p75
RT   neurotrophin receptor.";
RL   NeuroMolecular Med. 1:153-170(2002).
RN   [8]
RP   INTERACTION WITH NTRK1 AND KIDINS220, AND DOMAIN.
RX   PubMed=15378608; DOI=10.1002/jnr.20262;
RA   Chang M.-S., Arevalo J.C., Chao M.V.;
RT   "Ternary complex with Trk, p75, and an ankyrin-rich membrane spanning
RT   protein.";
RL   J. Neurosci. Res. 78:186-192(2004).
RN   [9]
RP   INTERACTION WITH BEX1.
RX   PubMed=16498402; DOI=10.1038/sj.emboj.7601017;
RA   Vilar M., Murillo-Carretero M., Mira H., Magnusson K., Besset V.,
RA   Ibanez C.F.;
RT   "Bex1, a novel interactor of the p75 neurotrophin receptor, links
RT   neurotrophin signaling to the cell cycle.";
RL   EMBO J. 25:1219-1230(2006).
RN   [10]
RP   FUNCTION, INTERACTION WITH TRIO; SORCS2 AND NGF, SUBUNIT, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=22155786; DOI=10.1126/scisignal.2002060;
RA   Deinhardt K., Kim T., Spellman D.S., Mains R.E., Eipper B.A., Neubert T.A.,
RA   Chao M.V., Hempstead B.L.;
RT   "Neuronal growth cone retraction relies on proneurotrophin receptor
RT   signaling through Rac.";
RL   Sci. Signal. 4:RA82-RA82(2011).
RN   [11]
RP   INTERACTION WITH SORCS2, FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=24908487; DOI=10.1016/j.neuron.2014.04.022;
RA   Glerup S., Olsen D., Vaegter C.B., Gustafsen C., Sjoegaard S.S., Hermey G.,
RA   Kjolby M., Molgaard S., Ulrichsen M., Boggild S., Skeldal S.,
RA   Fjorback A.N., Nyengaard J.R., Jacobsen J., Bender D., Bjarkam C.R.,
RA   Soerensen E.S., Fuechtbauer E.M., Eichele G., Madsen P., Willnow T.E.,
RA   Petersen C.M., Nykjaer A.;
RT   "SorCS2 regulates dopaminergic wiring and is processed into an apoptotic
RT   two-chain receptor in peripheral glia.";
RL   Neuron 82:1074-1087(2014).
RN   [12]
RP   INTERACTION WITH SORCS2.
RX   PubMed=27457814; DOI=10.1038/mp.2016.108;
RA   Glerup S., Bolcho U., Moelgaard S., Boeggild S., Vaegter C.B., Smith A.H.,
RA   Nieto-Gonzalez J.L., Ovesen P.L., Pedersen L.F., Fjorback A.N., Kjolby M.,
RA   Login H., Holm M.M., Andersen O.M., Nyengaard J.R., Willnow T.E.,
RA   Jensen K., Nykjaer A.;
RT   "SorCS2 is required for BDNF-dependent plasticity in the hippocampus.";
RL   Mol. Psychiatry 21:1740-1751(2016).
RN   [13] {ECO:0007744|PDB:1NGR}
RP   STRUCTURE BY NMR OF 334-418.
RX   PubMed=9305641; DOI=10.1093/emboj/16.16.4999;
RA   Liepinsh E., Ilag L.L., Otting G., Ibanez C.F.;
RT   "NMR structure of the death domain of the p75 neurotrophin receptor.";
RL   EMBO J. 16:4999-5005(1997).
RN   [14] {ECO:0007744|PDB:1SG1}
RP   X-RAY CRYSTALLOGRAPHY (2.40 ANGSTROMS) OF 30-190 IN COMPLEX WITH NGF,
RP   FUNCTION, AND DISULFIDE BONDS.
RX   PubMed=15131306; DOI=10.1126/science.1095190;
RA   He X.L., Garcia K.C.;
RT   "Structure of nerve growth factor complexed with the shared neurotrophin
RT   receptor p75.";
RL   Science 304:870-875(2004).
RN   [15] {ECO:0007744|PDB:3BUK}
RP   X-RAY CRYSTALLOGRAPHY (2.60 ANGSTROMS) OF 30-190 IN COMPLEX WITH NTF3,
RP   FUNCTION, GLYCOSYLATION AT ASN-61, AND DISULFIDE BONDS.
RX   PubMed=18596692; DOI=10.1038/nature07089;
RA   Gong Y., Cao P., Yu H.J., Jiang T.;
RT   "Crystal structure of the neurotrophin-3 and p75NTR symmetrical complex.";
RL   Nature 454:789-793(2008).
RN   [16] {ECO:0007744|PDB:3IJ2}
RP   X-RAY CRYSTALLOGRAPHY (3.75 ANGSTROMS) OF 30-190 OF MUTANT ASP-61 IN
RP   COMPLEX WITH NGF, FUNCTION, SUBCELLULAR LOCATION, DISULFIDE BONDS,
RP   GLYCOSYLATION AT ASN-61, AND MUTAGENESIS OF ASN-61.
RX   PubMed=20036257; DOI=10.1016/j.jmb.2009.12.030;
RA   Feng D., Kim T., Ozkan E., Light M., Torkin R., Teng K.K., Hempstead B.L.,
RA   Garcia K.C.;
RT   "Molecular and structural insight into proNGF engagement of p75NTR and
RT   sortilin.";
RL   J. Mol. Biol. 396:967-984(2010).
RN   [17] {ECO:0007744|PDB:2MIC, ECO:0007744|PDB:2MJO}
RP   STRUCTURE BY NMR OF 244-284, SUBUNIT, PROTEOLYTIC CLEAVAGE, AND MUTAGENESIS
RP   OF CYS-257; ALA-262 AND GLY-266.
RX   PubMed=27056327; DOI=10.1074/jbc.m116.723585;
RA   Nadezhdin K.D., Garcia-Carpio I., Goncharuk S.A., Mineev K.S.,
RA   Arseniev A.S., Vilar M.;
RT   "Structural Basis of p75 Transmembrane Domain Dimerization.";
RL   J. Biol. Chem. 291:12346-12357(2016).
CC   -!- FUNCTION: Low affinity receptor which can bind to NGF, BDNF, NTF3, and
CC       NTF4 (PubMed:15131306, PubMed:18596692, PubMed:3027580). Forms a
CC       heterodimeric receptor with SORCS2 that binds the precursor forms of
CC       NGF, BDNF and NTF3 with high affinity, and has much lower affinity for
CC       mature NGF and BDNF (PubMed:22155786, PubMed:24908487). In response to
CC       proNGF binding, the heterodimeric receptor with SORCS2 activates a
CC       signaling cascade that leads to decreased Rac activity, reorganization
CC       of the actin cytoskeleton and neuronal growth cone collapse
CC       (PubMed:22155786). Plays an important role in differentiation and
CC       survival of specific neuronal populations during development (By
CC       similarity). Can mediate cell survival as well as cell death of neural
CC       cells (PubMed:10514511, PubMed:10985348, PubMed:24908487). Plays a role
CC       in the inactivation of RHOA (By similarity). Plays a role in the
CC       regulation of the translocation of GLUT4 to the cell surface in
CC       adipocytes and skeletal muscle cells in response to insulin, probably
CC       by regulating RAB31 activity, and thereby contributes to the regulation
CC       of insulin-dependent glucose uptake (By similarity). Necessary for the
CC       circadian oscillation of the clock genes BMAL1, PER1, PER2 and NR1D1 in
CC       the suprachiasmatic nucleus (SCN) of the brain and in liver and of the
CC       genes involved in glucose and lipid metabolism in the liver (By
CC       similarity). {ECO:0000250|UniProtKB:P08138,
CC       ECO:0000250|UniProtKB:Q9Z0W1, ECO:0000269|PubMed:10514511,
CC       ECO:0000269|PubMed:10985348, ECO:0000269|PubMed:15131306,
CC       ECO:0000269|PubMed:18596692, ECO:0000269|PubMed:22155786,
CC       ECO:0000269|PubMed:24908487, ECO:0000269|PubMed:3027580}.
CC   -!- SUBUNIT: Homodimer; disulfide-linked (PubMed:27056327). Heterodimer
CC       with SORCS2 (PubMed:22155786, PubMed:24908487, PubMed:27457814). The
CC       extracellular domains of the heterodimer bind NGF (PubMed:22155786,
CC       PubMed:24908487). The cytoplasmic region of the heterodimer binds TRIO.
CC       NGF binding mediates dissociation of TRIO from the receptor complex
CC       (PubMed:22155786). Interacts with RTN4R (By similarity). Interacts with
CC       TRAF2, TRAF4 and TRAF6 (PubMed:10514511). Interacts with PTPN13 and
CC       RANBP9. Interacts through TRAF6 with SQSTM1 which bridges NGFR to NTRK1
CC       (By similarity). Interacts with BEX1 (PubMed:16498402). Interacts with
CC       BEX3 (By similarity). Interacts with KIDINS220 and NTRK1. Can form a
CC       ternary complex with NTRK1 and KIDINS220 and this complex is affected
CC       by the expression levels of KIDINS220. An increase in KIDINS220
CC       expression leads to a decreased association of NGFR and NTRK1
CC       (PubMed:11150334, PubMed:15378608). Interacts (via death domain) with
CC       RAB31 (By similarity). Interacts with NTRK2; may regulate the ligand
CC       specificity of the NTRK2 receptor (PubMed:9927421). Interacts with
CC       LINGO1 (By similarity). Interacts with NRADD (PubMed:12095158).
CC       Interacts with MAGED1; the interaction antagonizes the association
CC       NGFR:NTRK1 (PubMed:10985348). Interacts (via death domain) with ARHGDIA
CC       and RIPK2 (By similarity). {ECO:0000250|UniProtKB:P08138,
CC       ECO:0000250|UniProtKB:Q9Z0W1, ECO:0000269|PubMed:10514511,
CC       ECO:0000269|PubMed:10985348, ECO:0000269|PubMed:11150334,
CC       ECO:0000269|PubMed:12095158, ECO:0000269|PubMed:15378608,
CC       ECO:0000269|PubMed:16498402, ECO:0000269|PubMed:22155786,
CC       ECO:0000269|PubMed:24908487, ECO:0000269|PubMed:27056327,
CC       ECO:0000269|PubMed:27457814, ECO:0000269|PubMed:9927421}.
CC   -!- INTERACTION:
CC       P07174; Q3MKQ2: Bex1; NbExp=4; IntAct=EBI-1038810, EBI-8089575;
CC       P07174; P07174: Ngfr; NbExp=2; IntAct=EBI-1038810, EBI-1038810;
CC       P07174; P35739: Ntrk1; NbExp=2; IntAct=EBI-1038810, EBI-976667;
CC       P07174; PRO_0000000093 [P05067]: APP; Xeno; NbExp=2; IntAct=EBI-1038810, EBI-2431589;
CC       P07174; P01138: NGF; Xeno; NbExp=3; IntAct=EBI-1038810, EBI-1028250;
CC       P07174; P20783: NTF3; Xeno; NbExp=4; IntAct=EBI-1038810, EBI-1025994;
CC       P07174; Q12933: TRAF2; Xeno; NbExp=3; IntAct=EBI-1038810, EBI-355744;
CC       P07174; Q9BUZ4: TRAF4; Xeno; NbExp=3; IntAct=EBI-1038810, EBI-3650647;
CC       P07174; Q9Y4K3: TRAF6; Xeno; NbExp=2; IntAct=EBI-1038810, EBI-359276;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:20036257,
CC       ECO:0000269|PubMed:22155786, ECO:0000269|PubMed:24908487,
CC       ECO:0000269|PubMed:3027580}; Single-pass type I membrane protein
CC       {ECO:0000305}. Perikaryon {ECO:0000269|PubMed:22155786}. Cell
CC       projection, growth cone {ECO:0000269|PubMed:22155786}. Cell projection,
CC       dendritic spine {ECO:0000250|UniProtKB:Q9Z0W1}.
CC   -!- DOMAIN: Death domain is responsible for interaction with RANBP9. It
CC       also mediates interaction with ARHGDIA and RIPK2 (By similarity).
CC       {ECO:0000250|UniProtKB:P08138, ECO:0000269|PubMed:15378608}.
CC   -!- DOMAIN: The extracellular domain is responsible for interaction with
CC       NTRK1. {ECO:0000269|PubMed:15378608}.
CC   -!- PTM: Subject to intramembrane proteolytic cleavage by the gamma-
CC       secretase complex, giving rise to an intracellular fragment that is
CC       rapidly degraded via the proteasome. {ECO:0000269|PubMed:27056327}.
CC   -!- PTM: N- and O-glycosylated. {ECO:0000269|PubMed:20036257}.
CC   -!- PTM: Phosphorylated on serine residues.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X05137; CAA28783.1; -; mRNA.
DR   EMBL; X61269; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   PIR; A26431; A26431.
DR   RefSeq; NP_036742.2; NM_012610.2.
DR   PDB; 1NGR; NMR; -; A=334-418.
DR   PDB; 1SG1; X-ray; 2.40 A; X=30-190.
DR   PDB; 2MIC; NMR; -; A/B=245-284.
DR   PDB; 2MJO; NMR; -; A/B=245-284.
DR   PDB; 3BUK; X-ray; 2.60 A; C/D=30-190.
DR   PDB; 3IJ2; X-ray; 3.75 A; X/Y=30-190.
DR   PDB; 4F42; X-ray; 2.38 A; A=334-418.
DR   PDB; 4F44; X-ray; 2.40 A; A/B=334-418.
DR   PDBsum; 1NGR; -.
DR   PDBsum; 1SG1; -.
DR   PDBsum; 2MIC; -.
DR   PDBsum; 2MJO; -.
DR   PDBsum; 3BUK; -.
DR   PDBsum; 3IJ2; -.
DR   PDBsum; 4F42; -.
DR   PDBsum; 4F44; -.
DR   AlphaFoldDB; P07174; -.
DR   BMRB; P07174; -.
DR   SMR; P07174; -.
DR   BioGRID; 246737; 15.
DR   CORUM; P07174; -.
DR   DIP; DIP-5715N; -.
DR   IntAct; P07174; 20.
DR   MINT; P07174; -.
DR   STRING; 10116.ENSRNOP00000007268; -.
DR   ChEMBL; CHEMBL4523169; -.
DR   GlyCosmos; P07174; 2 sites, No reported glycans.
DR   GlyGen; P07174; 2 sites.
DR   iPTMnet; P07174; -.
DR   PhosphoSitePlus; P07174; -.
DR   SwissPalm; P07174; -.
DR   jPOST; P07174; -.
DR   PaxDb; 10116-ENSRNOP00000007268; -.
DR   GeneID; 24596; -.
DR   KEGG; rno:24596; -.
DR   UCSC; RGD:3177; rat.
DR   AGR; RGD:3177; -.
DR   CTD; 4804; -.
DR   RGD; 3177; Ngfr.
DR   eggNOG; ENOG502QWPN; Eukaryota.
DR   InParanoid; P07174; -.
DR   OrthoDB; 4222274at2759; -.
DR   PhylomeDB; P07174; -.
DR   Reactome; R-RNO-193634; Axonal growth inhibition (RHOA activation).
DR   Reactome; R-RNO-193692; Regulated proteolysis of p75NTR.
DR   Reactome; R-RNO-205017; NFG and proNGF binds to p75NTR.
DR   Reactome; R-RNO-205025; NADE modulates death signalling.
DR   Reactome; R-RNO-205043; NRIF signals cell death from the nucleus.
DR   Reactome; R-RNO-209543; p75NTR recruits signalling complexes.
DR   Reactome; R-RNO-209560; NF-kB is activated and signals survival.
DR   Reactome; R-RNO-209563; Axonal growth stimulation.
DR   EvolutionaryTrace; P07174; -.
DR   PRO; PR:P07174; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0009986; C:cell surface; ISO:RGD.
DR   GO; GO:0005911; C:cell-cell junction; ISO:RGD.
DR   GO; GO:0045334; C:clathrin-coated endocytic vesicle; IDA:RGD.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0032590; C:dendrite membrane; IDA:RGD.
DR   GO; GO:0043197; C:dendritic spine; IEA:UniProtKB-SubCell.
DR   GO; GO:0009897; C:external side of plasma membrane; IDA:RGD.
DR   GO; GO:0030426; C:growth cone; IEA:UniProtKB-SubCell.
DR   GO; GO:0005739; C:mitochondrion; IDA:RGD.
DR   GO; GO:0031594; C:neuromuscular junction; IDA:SynGO.
DR   GO; GO:0032809; C:neuronal cell body membrane; IDA:RGD.
DR   GO; GO:0005635; C:nuclear envelope; IDA:RGD.
DR   GO; GO:0043204; C:perikaryon; IDA:RGD.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0014069; C:postsynaptic density; ISO:RGD.
DR   GO; GO:0042734; C:presynaptic membrane; IDA:SynGO.
DR   GO; GO:0001540; F:amyloid-beta binding; IPI:RGD.
DR   GO; GO:0005516; F:calmodulin binding; ISS:UniProtKB.
DR   GO; GO:0015026; F:coreceptor activity; ISO:RGD.
DR   GO; GO:0005035; F:death receptor activity; ISO:RGD.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0048406; F:nerve growth factor binding; IDA:RGD.
DR   GO; GO:0043121; F:neurotrophin binding; IPI:RGD.
DR   GO; GO:0005168; F:neurotrophin TRKA receptor binding; IPI:RGD.
DR   GO; GO:0070678; F:preprotein binding; IPI:RGD.
DR   GO; GO:0044877; F:protein-containing complex binding; IPI:RGD.
DR   GO; GO:0031267; F:small GTPase binding; ISS:UniProtKB.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; ISO:RGD.
DR   GO; GO:0007411; P:axon guidance; ISO:RGD.
DR   GO; GO:1904646; P:cellular response to amyloid-beta; ISO:RGD.
DR   GO; GO:0034599; P:cellular response to oxidative stress; IMP:RGD.
DR   GO; GO:0007417; P:central nervous system development; ISO:RGD.
DR   GO; GO:0032922; P:circadian regulation of gene expression; ISS:UniProtKB.
DR   GO; GO:0007623; P:circadian rhythm; ISO:RGD.
DR   GO; GO:0016048; P:detection of temperature stimulus; ISO:RGD.
DR   GO; GO:0035907; P:dorsal aorta development; ISO:RGD.
DR   GO; GO:0008543; P:fibroblast growth factor receptor signaling pathway; ISO:RGD.
DR   GO; GO:0048144; P:fibroblast proliferation; ISO:RGD.
DR   GO; GO:0042593; P:glucose homeostasis; ISS:UniProtKB.
DR   GO; GO:0001942; P:hair follicle development; ISO:RGD.
DR   GO; GO:0031069; P:hair follicle morphogenesis; ISO:RGD.
DR   GO; GO:0001678; P:intracellular glucose homeostasis; ISS:UniProtKB.
DR   GO; GO:0006886; P:intracellular protein transport; ISS:UniProtKB.
DR   GO; GO:0016525; P:negative regulation of angiogenesis; IMP:RGD.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IMP:RGD.
DR   GO; GO:1903588; P:negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis; ISO:RGD.
DR   GO; GO:0030336; P:negative regulation of cell migration; ISO:RGD.
DR   GO; GO:0061000; P:negative regulation of dendritic spine development; IMP:RGD.
DR   GO; GO:0040037; P:negative regulation of fibroblast growth factor receptor signaling pathway; ISO:RGD.
DR   GO; GO:0051799; P:negative regulation of hair follicle development; ISO:RGD.
DR   GO; GO:0051902; P:negative regulation of mitochondrial depolarization; IMP:RGD.
DR   GO; GO:0043524; P:negative regulation of neuron apoptotic process; IMP:RGD.
DR   GO; GO:0010977; P:negative regulation of neuron projection development; IDA:RGD.
DR   GO; GO:0021675; P:nerve development; ISO:RGD.
DR   GO; GO:0051402; P:neuron apoptotic process; ISO:RGD.
DR   GO; GO:0042475; P:odontogenesis of dentin-containing tooth; ISO:RGD.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IMP:RGD.
DR   GO; GO:2001235; P:positive regulation of apoptotic signaling pathway; ISO:RGD.
DR   GO; GO:2000463; P:positive regulation of excitatory postsynaptic potential; IMP:RGD.
DR   GO; GO:0048146; P:positive regulation of fibroblast proliferation; ISO:RGD.
DR   GO; GO:0043410; P:positive regulation of MAPK cascade; IDA:RGD.
DR   GO; GO:1902895; P:positive regulation of miRNA transcription; ISO:RGD.
DR   GO; GO:0031643; P:positive regulation of myelination; IMP:RGD.
DR   GO; GO:2000179; P:positive regulation of neural precursor cell proliferation; IMP:RGD.
DR   GO; GO:0045666; P:positive regulation of neuron differentiation; IDA:RGD.
DR   GO; GO:0010976; P:positive regulation of neuron projection development; IMP:RGD.
DR   GO; GO:0042488; P:positive regulation of odontogenesis of dentin-containing tooth; ISO:RGD.
DR   GO; GO:0051897; P:positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction; IDA:RGD.
DR   GO; GO:1900182; P:positive regulation of protein localization to nucleus; ISO:RGD.
DR   GO; GO:0035025; P:positive regulation of Rho protein signal transduction; IDA:RGD.
DR   GO; GO:0032224; P:positive regulation of synaptic transmission, cholinergic; IMP:RGD.
DR   GO; GO:0051968; P:positive regulation of synaptic transmission, glutamatergic; IMP:RGD.
DR   GO; GO:0099171; P:presynaptic modulation of chemical synaptic transmission; ISO:RGD.
DR   GO; GO:0010468; P:regulation of gene expression; ISO:RGD.
DR   GO; GO:2000377; P:regulation of reactive oxygen species metabolic process; IMP:RGD.
DR   GO; GO:0045471; P:response to ethanol; IEP:RGD.
DR   GO; GO:0032496; P:response to lipopolysaccharide; IEP:RGD.
DR   GO; GO:0007266; P:Rho protein signal transduction; ISO:RGD.
DR   GO; GO:0035914; P:skeletal muscle cell differentiation; IEP:RGD.
DR   GO; GO:0043588; P:skin development; ISO:RGD.
DR   GO; GO:0007283; P:spermatogenesis; IEP:RGD.
DR   CDD; cd08311; Death_p75NR; 1.
DR   CDD; cd13416; TNFRSF16; 1.
DR   Gene3D; 6.10.250.1780; -; 1.
DR   Gene3D; 1.10.533.10; Death Domain, Fas; 1.
DR   Gene3D; 2.10.50.10; Tumor Necrosis Factor Receptor, subunit A, domain 2; 4.
DR   InterPro; IPR011029; DEATH-like_dom_sf.
DR   InterPro; IPR000488; Death_domain.
DR   InterPro; IPR052302; Neurotrophin_rcpt-DD.
DR   InterPro; IPR001368; TNFR/NGFR_Cys_rich_reg.
DR   InterPro; IPR041448; TNFR16_TM.
DR   InterPro; IPR022325; TNFR_16.
DR   InterPro; IPR034046; TNFRSF16_N.
DR   PANTHER; PTHR46605; TUMOR NECROSIS FACTOR RECEPTOR; 1.
DR   PANTHER; PTHR46605:SF3; TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 16; 1.
DR   Pfam; PF00531; Death; 1.
DR   Pfam; PF18422; TNFR_16_TM; 1.
DR   Pfam; PF00020; TNFR_c6; 3.
DR   PRINTS; PR01966; TNFACTORR16.
DR   SMART; SM00005; DEATH; 1.
DR   SMART; SM00208; TNFR; 4.
DR   SUPFAM; SSF47986; DEATH domain; 1.
DR   SUPFAM; SSF57586; TNF receptor-like; 4.
DR   PROSITE; PS50017; DEATH_DOMAIN; 1.
DR   PROSITE; PS00652; TNFR_NGFR_1; 3.
DR   PROSITE; PS50050; TNFR_NGFR_2; 4.
PE   1: Evidence at protein level;
KW   3D-structure; Apoptosis; Biological rhythms; Cell membrane;
KW   Cell projection; Developmental protein; Differentiation; Disulfide bond;
KW   Glycoprotein; Membrane; Neurogenesis; Phosphoprotein; Receptor;
KW   Reference proteome; Repeat; Signal; Synapse; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL          1..29
FT   CHAIN           30..425
FT                   /note="Tumor necrosis factor receptor superfamily member
FT                   16"
FT                   /id="PRO_0000034593"
FT   TOPO_DOM        30..253
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        254..274
FT                   /note="Helical"
FT                   /evidence="ECO:0000305|PubMed:27056327"
FT   TOPO_DOM        275..425
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   REPEAT          32..65
FT                   /note="TNFR-Cys 1"
FT   REPEAT          67..108
FT                   /note="TNFR-Cys 2"
FT   REPEAT          109..147
FT                   /note="TNFR-Cys 3"
FT   REPEAT          149..189
FT                   /note="TNFR-Cys 4"
FT   DOMAIN          354..419
FT                   /note="Death"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00064"
FT   REGION          193..225
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          282..332
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          327..342
FT                   /note="Mediates interaction with KIDINS220"
FT   COMPBIAS        202..216
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        306..332
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         312
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P08138"
FT   CARBOHYD        61
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000305|PubMed:20036257,
FT                   ECO:0007744|PDB:3BUK"
FT   CARBOHYD        71
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        33..44
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00206,
FT                   ECO:0007744|PDB:1SG1, ECO:0007744|PDB:3BUK,
FT                   ECO:0007744|PDB:3IJ2"
FT   DISULFID        45..58
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00206,
FT                   ECO:0007744|PDB:1SG1, ECO:0007744|PDB:3BUK,
FT                   ECO:0007744|PDB:3IJ2"
FT   DISULFID        48..65
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00206,
FT                   ECO:0007744|PDB:1SG1, ECO:0007744|PDB:3BUK,
FT                   ECO:0007744|PDB:3IJ2"
FT   DISULFID        68..84
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00206,
FT                   ECO:0007744|PDB:1SG1, ECO:0007744|PDB:3BUK,
FT                   ECO:0007744|PDB:3IJ2"
FT   DISULFID        87..100
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00206,
FT                   ECO:0007744|PDB:1SG1, ECO:0007744|PDB:3BUK,
FT                   ECO:0007744|PDB:3IJ2"
FT   DISULFID        90..108
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00206,
FT                   ECO:0007744|PDB:1SG1, ECO:0007744|PDB:3BUK,
FT                   ECO:0007744|PDB:3IJ2"
FT   DISULFID        110..123
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00206,
FT                   ECO:0007744|PDB:1SG1, ECO:0007744|PDB:3BUK,
FT                   ECO:0007744|PDB:3IJ2"
FT   DISULFID        126..139
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00206,
FT                   ECO:0007744|PDB:1SG1, ECO:0007744|PDB:3BUK,
FT                   ECO:0007744|PDB:3IJ2"
FT   DISULFID        129..147
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00206,
FT                   ECO:0007744|PDB:1SG1, ECO:0007744|PDB:3BUK,
FT                   ECO:0007744|PDB:3IJ2"
FT   DISULFID        150..165
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00206,
FT                   ECO:0007744|PDB:1SG1, ECO:0007744|PDB:3BUK,
FT                   ECO:0007744|PDB:3IJ2"
FT   DISULFID        168..181
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00206,
FT                   ECO:0007744|PDB:1SG1, ECO:0007744|PDB:3BUK,
FT                   ECO:0007744|PDB:3IJ2"
FT   DISULFID        171..189
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00206,
FT                   ECO:0007744|PDB:1SG1, ECO:0007744|PDB:3BUK,
FT                   ECO:0007744|PDB:3IJ2"
FT   MUTAGEN         61
FT                   /note="N->D: Loss of a glycosylation site."
FT                   /evidence="ECO:0000269|PubMed:20036257"
FT   MUTAGEN         257
FT                   /note="C->A: Alters mode of dimerization, but does not
FT                   abolish dimerization."
FT                   /evidence="ECO:0000269|PubMed:27056327"
FT   MUTAGEN         257
FT                   /note="C->I: No effect on dimerization. Loss of
FT                   dimerization; when associated with I-266."
FT                   /evidence="ECO:0000269|PubMed:27056327"
FT   MUTAGEN         262
FT                   /note="A->I: No effect on dimerization."
FT                   /evidence="ECO:0000269|PubMed:27056327"
FT   MUTAGEN         266
FT                   /note="G->I: No effect on dimerization. Loss of
FT                   dimerization; when associated with I-257."
FT                   /evidence="ECO:0000269|PubMed:27056327"
FT   STRAND          40..45
FT                   /evidence="ECO:0007829|PDB:3BUK"
FT   STRAND          52..56
FT                   /evidence="ECO:0007829|PDB:1SG1"
FT   STRAND          58..62
FT                   /evidence="ECO:0007829|PDB:1SG1"
FT   STRAND          64..67
FT                   /evidence="ECO:0007829|PDB:1SG1"
FT   TURN            70..72
FT                   /evidence="ECO:0007829|PDB:1SG1"
FT   STRAND          79..81
FT                   /evidence="ECO:0007829|PDB:1SG1"
FT   STRAND          94..98
FT                   /evidence="ECO:0007829|PDB:1SG1"
FT   STRAND          107..110
FT                   /evidence="ECO:0007829|PDB:1SG1"
FT   STRAND          114..116
FT                   /evidence="ECO:0007829|PDB:1SG1"
FT   TURN            118..120
FT                   /evidence="ECO:0007829|PDB:1SG1"
FT   STRAND          123..125
FT                   /evidence="ECO:0007829|PDB:1SG1"
FT   STRAND          133..137
FT                   /evidence="ECO:0007829|PDB:1SG1"
FT   STRAND          146..149
FT                   /evidence="ECO:0007829|PDB:1SG1"
FT   STRAND          160..162
FT                   /evidence="ECO:0007829|PDB:1SG1"
FT   TURN            246..249
FT                   /evidence="ECO:0007829|PDB:2MIC"
FT   STRAND          250..253
FT                   /evidence="ECO:0007829|PDB:2MIC"
FT   HELIX           255..275
FT                   /evidence="ECO:0007829|PDB:2MIC"
FT   TURN            276..278
FT                   /evidence="ECO:0007829|PDB:2MIC"
FT   HELIX           337..339
FT                   /evidence="ECO:0007829|PDB:4F42"
FT   HELIX           342..351
FT                   /evidence="ECO:0007829|PDB:4F42"
FT   TURN            352..355
FT                   /evidence="ECO:0007829|PDB:4F42"
FT   HELIX           356..364
FT                   /evidence="ECO:0007829|PDB:4F42"
FT   HELIX           368..373
FT                   /evidence="ECO:0007829|PDB:4F42"
FT   HELIX           374..376
FT                   /evidence="ECO:0007829|PDB:4F42"
FT   STRAND          377..379
FT                   /evidence="ECO:0007829|PDB:4F42"
FT   HELIX           380..388
FT                   /evidence="ECO:0007829|PDB:4F42"
FT   STRAND          391..393
FT                   /evidence="ECO:0007829|PDB:4F44"
FT   HELIX           396..405
FT                   /evidence="ECO:0007829|PDB:4F42"
FT   HELIX           409..416
FT                   /evidence="ECO:0007829|PDB:4F42"
SQ   SEQUENCE   425 AA;  45433 MW;  B2E152D94D3827F8 CRC64;
     MRRAGAACSA MDRLRLLLLL ILGVSSGGAK ETCSTGLYTH SGECCKACNL GEGVAQPCGA
     NQTVCEPCLD NVTFSDVVSA TEPCKPCTEC LGLQSMSAPC VEADDAVCRC AYGYYQDEET
     GHCEACSVCE VGSGLVFSCQ DKQNTVCEEC PEGTYSDEAN HVDPCLPCTV CEDTERQLRE
     CTPWADAECE EIPGRWIPRS TPPEGSDSTA PSTQEPEVPP EQDLVPSTVA DMVTTVMGSS
     QPVVTRGTTD NLIPVYCSIL AAVVVGLVAY IAFKRWNSCK QNKQGANSRP VNQTPPPEGE
     KLHSDSGISV DSQSLHDQQT HTQTASGQAL KGDGNLYSSL PLTKREEVEK LLNGDTWRHL
     AGELGYQPEH IDSFTHEACP VRALLASWGA QDSATLDALL AALRRIQRAD IVESLCSEST
     ATSPV
//
